Kromek Group PLC (AIM:KMK) said it has been awarded a US$1.5mln contract in the civil nuclear market to be delivered over the next 15 months.
The contract has been awarded by the radiation and bio-detection group’s partners in Asia. In a statement, the company said it is to supply three new end-customers in the region.
The order is for a new product, it added, based on the group’s existing technology with the development of the product funded by the distribution partner.
Designed for civil nuclear applications, the new product's functions include detecting, identifying and analysing radiological sources.
"It is great to have received our first order for this new product line as we commence the commercialisation phase,” said Kromek CEO Arnab Basu.
“It reflects the strength of our business model as another example of customer-funded development work transitioning to a product delivery phase. It is also indicative of the increasing interest that we are receiving in our CZT-based technology in the fast-growing Asian markets,” Basu added.